TOWARDS IMPROVED THROMBOLYTIC THERAPY

被引：43

作者：

COLLEN, D

机构：

[1] Center for Molecular and Vascular Biology, University of Leuven

来源：

LANCET | 1993年 / 342卷 / 8862期

关键词：

D O I：

10.1016/0140-6736(93)91888-S

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：34 / 36

页数：3

共 23 条

[1]

[Anonymous], 1986, Lancet, V1, P397

[2] ANTIBODY-DIRECTED UROKINASE - A SPECIFIC FIBRINOLYTIC AGENT [J].

BODE, C ;

MATSUEDA, GR ;

HUI, KY ;

HABER, E .

SCIENCE, 1985, 229 (4715) :765-767

[3] MYOCARDIAL REPERFUSION, LIMITATION OF INFARCT SIZE, REDUCTION OF LEFT-VENTRICULAR DYSFUNCTION, AND IMPROVED SURVIVAL - SHOULD THE PARADIGM BE EXPANDED [J].

BRAUNWALD, E .

CIRCULATION, 1989, 79 (02) :441-444

[4] THROMBOLYTIC AND PHARMACOKINETIC PROPERTIES OF CHIMERIC TISSUE-TYPE AND UROKINASE-TYPE PLASMINOGEN ACTIVATORS [J].

COLLEN, D ;

LU, HR ;

LIJNEN, HR ;

NELLES, L ;

STASSEN, JM .

CIRCULATION, 1991, 84 (03) :1216-1234

[5] COMPARATIVE IMMUNOGENICITY AND THROMBOLYTIC PROPERTIES TOWARD ARTERIAL AND VENOUS THROMBI OF STREPTOKINASE AND RECOMBINANT STAPHYLOKINASE IN BABOONS [J].

COLLEN, D ;

DECOCK, F ;

STASSEN, JM .

CIRCULATION, 1993, 87 (03) :996-1006

[6]

COLLEN D, 1991, BLOOD, V78, P3114

[7]

COLLEN D, IN PRESS CIRCULATION

[8]

COLLEN D, IN PRESS THROMB HAEM

[9]

DAVIES MJ, 1985, BRIT HEART J, V53, P363

[10] PREVALENCE OF TOTAL CORONARY-OCCLUSION DURING THE EARLY HOURS OF TRANSMURAL MYOCARDIAL-INFARCTION [J].

DEWOOD, MA ;

SPORES, J ;

NOTSKE, R ;

MOUSER, LT ;

BURROUGHS, R ;

GOLDEN, MS ;

LANG, HT .

NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (16) :897-902

← 1 2 3 →